Replay available

Novavax, Inc. (NVAX) Q1 2025 Earnings Call

Novavax, Inc. (NASDAQ: NVAX) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Thu, May 8, 2025 at 8:30 AMendedReplay
Novavax, Inc. (NVAX) Q1 2025 Earnings Call

Hosted by

Featured presenters

John Trezino

Chief Operating Officer

Mayank Mantani

Analyst, B. Riley Securities

Roger Song

Analyst, Jefferies

Chris Labianco

Analyst, ED Securities

Luis Sanay

Vice President, Investor Relations

Dr. Aksandra Draghia

Head of R&D

Jim Kelly

Chief Financial Officer and Treasurer

John Jacobs

President and CEO

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.218 Good morning and welcome to Novavax First Quarter 2025 Financial Results 00:00:05.218 -- 00:00:08.222 and Operational Highlights Conference Call. 00:00:08.222 -- 00:00:11.407 All participants will be in listen-only mode. 00:00:11.407 -- 00:00:15.793 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.793 -- 00:00:21.080 key followed by zero. After today's presentation, there will be an opportunity 00:00:21.080 -- 00:00:23.163 to ask questions. 00:00:23.163 -- 00:00:27.436 To ask a question, you may press star followed by the number one on your title. 00:00:27.436 -- 00:00:32.762 on phone. To withdraw your question, please press star followed by the number two. 00:00:32.762 -- 00:00:35.766 Please note, this event is being recorded. 00:00:35.766 -- 00:00:40.111 I would now like to turn the conference over to Luis Sanay, Vice President, Investor 00:00:40.111 -- 00:00:43.255 Relations. Please go ahead. 00:00:43.255 -- 00:00:47.761 Good morning and thank you all for joining us today to discuss our first quarter 2025 00:00:47.761 -- 00:00:51.645 financial results and operational highlights. 00:00:51.645 -- 00:00:57.237 A press release announcing our results is currently available on our website at novavax.com 00:00:57.237 -- 00:01:03.246 and an audio archive of this conference call will be available on our website later today. 00:01:03.246 -- 00:01:08.374 Please turn to slide two. Before we begin with prepared remarks, I need to 00:01:08.374 -- 00:01:12.941 remind you that this presentation includes forward-looking statements, including but 00:01:12.941 -- 00:01:18.809 not limited to statements related to Novavax's corporate strategy and operating plans, 00:01:18.809 -- 00:01:24.057 its strateg...